Medicare Enrolled
Dr. Jennifer Byer, MD
Hematology · Vero Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Byer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Byer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Byer
Dr. Jennifer Byer is a hematology specialist in Vero Beach, FL, with 15 years of NPI registration. Based on federal Medicare data, Dr. Byer performed 247,310 Medicare services across 9,128 unique beneficiaries.
Between the years covered by Open Payments, Dr. Byer received a total of $20,223 from 84 pharmaceutical and/or device companies across 1146 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Byer is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 13% volume in FL
$20,223 industry payments
Medicare Practice Summary
Medicare Utilization ↗247,310
Medicare services
Top 13% in FL for hematology
9,128
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~16,487 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
75,480 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 34,800 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 18,720 | $1 | $5 |
| Paclitaxel chemotherapy injection | 15,404 | $0 | $2 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
15,300 | $38 | $110 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
9,860 | $0 | $12 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
8,177 | $6 | $23 |
| Nivolumab injection (Opdivo) | 7,120 | $24 | $72 |
| Denosumab injection (Prolia/Xgeva) | 6,360 | $18 | $51 |
| Eflapegrastim injection, 0.1 mg An injection of eflapegrastim-xnst administered at a dose of 0.1 mg. |
5,016 | $25 | $116 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
4,184 | $36 | $108 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
3,900 | $0 | $5 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
3,541 | $8 | $29 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,416 | $0 | $3 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
3,141 | $8 | $9 |
| Injection, durvalumab, 10 mg | 3,023 | $62 | $191 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
2,901 | $6 | $22 |
| Iron infusion (Monoferric) | 2,900 | $16 | $57 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,250 | $1 | $28 |
| Bortezomib injection, 0.1 mg Administration of a 0.1 mg dose of bortezomib medication via injection. |
2,049 | $4 | $113 |
| Injection, docetaxel, 1 mg | 1,857 | $1 | $7 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,680 | $69 | $239 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,640 | $0 | $1 |
| Anti-nausea injection (ondansetron/Zofran) | 1,120 | $0 | $9 |
| Injection, atropine sulfate, 0.01 mg | 1,000 | $0 | $1 |
| Injection, leucovorin calcium, per 50 mg | 978 | $3 | $12 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
937 | $11 | $69 |
| Injection, fulvestrant, 25 mg | 760 | $9 | $132 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
720 | $104 | $378 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
702 | $12 | $61 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
636 | $2 | $8 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 618 | $3 | $205 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
548 | $2 | $7 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
406 | $2 | $41 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
402 | $1 | $6 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
331 | $23 | $84 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
313 | $50 | $189 |
| Cyclophosphamide, 100 mg | 313 | $16 | $79 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
310 | $82 | $297 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
308 | $1 | $3 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
302 | $4 | $10 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
288 | $23 | $79 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
239 | $52 | $178 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
226 | $100 | $339 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
206 | $6 | $69 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 187 | $135 | $562 |
| Doxorubicin hydrochloride injection, 10 mg This procedure involves the administration of a 10 mg dose of doxorubicin hydrochloride via injection. |
184 | $2 | $13 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
170 | $2 | $13 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
161 | $56 | $206 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
152 | $25 | $89 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
142 | $2 | $7 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
134 | $8 | $51 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
131 | $30 | $156 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
129 | $16 | $56 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
128 | $103 | $344 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
120 | $8 | $135 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
101 | $25 | $156 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
89 | $18 | $59 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
86 | $121 | $453 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
86 | $1 | $2 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
77 | $1 | $7 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
72 | $28 | $128 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
63 | $133 | $637 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
60 | $97 | $285 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
59 | $27 | $517 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
58 | $45 | $170 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
57 | $152 | $295 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
51 | $10 | $42 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
44 | $77 | $277 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
40 | $93 | $335 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
35 | $16 | $56 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
34 | $299 | $894 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
33 | $77 | $298 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
31 | $41 | $147 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
31 | $64 | $197 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
26 | $3 | $11 |
| Injection, lorazepam, 2 mg | 24 | $1 | $2 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
23 | $294 | $827 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $140 | $556 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
19 | $199 | $708 |
| New patient office visit, complex (60-74 min) | 17 | $168 | $585 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
15 | $145 | $474 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
15 | $105 | $377 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
13 | $61 | $177 |
| 3D radiographic procedure with computerized image postprocessing A radiographic imaging procedure that creates three-dimensional images using computerized processing of the captured data. |
11 | $31 | $82 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
34.2% high complexity
61.4% medium
4.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$20,223
Total received (2018-2024)
Avg $2,889/year across 7 years
Top 23% in FL for hematology
84
Companies
1,146
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,120 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$104 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,599
2023
$2,915
2022
$3,638
2021
$3,227
2020
$2,587
2019
$2,749
2018
$3,509
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$1,505
Novartis Pharmaceuticals Corporation
$1,490
AstraZeneca Pharmaceuticals LP
$1,348
PFIZER INC.
$1,259
Janssen Biotech, Inc.
$1,197
Celgene Corporation
$1,187
Amgen Inc.
$1,163
GlaxoSmithKline, LLC.
$730
Merck Sharp & Dohme Corporation
$677
Seagen Inc.
$594
GENZYME CORPORATION
$535
Daiichi Sankyo Inc.
$529
Bayer HealthCare Pharmaceuticals Inc.
$523
Incyte Corporation
$483
Pharmacyclics LLC, An AbbVie Company
$441
Lilly USA, LLC
$414
Ipsen Biopharmaceuticals, Inc
$338
Merck Sharp & Dohme LLC
$332
TESARO, Inc.
$326
Takeda Pharmaceuticals U.S.A., Inc.
$306
Gilead Sciences, Inc.
$275
ARRAY BIOPHARMA INC
$239
JAZZ PHARMACEUTICALS INC.
$232
Genentech USA, Inc.
$217
Taiho Oncology, Inc.
$210
Astellas Pharma US Inc
$198
Boehringer Ingelheim Pharmaceuticals, Inc.
$193
EISAI INC.
$184
BeiGene USA, Inc.
$168
AMAG Pharmaceuticals, Inc.
$161
Regeneron Healthcare Solutions, Inc.
$159
ABBVIE INC.
$139
Clovis Oncology, Inc.
$137
Eisai Inc.
$131
AbbVie Inc.
$126
Puma Biotechnology, Inc.
$118
Alexion Pharmaceuticals, Inc.
$114
Boston Scientific Corporation
$109
PUMA BIOTECHNOLOGY, INC.
$103
AVEO Pharmaceuticals, Inc.
$92
Dova Pharmaceuticals
$89
Bayer Healthcare Pharmaceuticals Inc.
$86
Aveo Pharmaceuticals, Inc.
$81
Pharmacyclics LLC, an AbbVie Company
$77
Myovant Sciences Inc.
$70
TerSera Therapeutics LLC
$66
Karyopharm Therapeutics Inc.
$66
EUSA Pharma (US) LLC
$58
Myriad Genetic Laboratories, Inc.
$53
Fennec Pharmaceuticals, Inc.
$49
AbbVie, Inc.
$48
Rigel Pharmaceuticals, Inc.
$47
Biocon Biologics Inc
$46
Dendreon Pharmaceuticals LLC
$45
EMD Serono, Inc.
$44
Kite Pharma, Inc.
$41
MorphoSys, US Inc.
$39
Agios Pharmaceuticals, Inc.
$36
Helsinn Therapeutics (U.S.), Inc.
$35
Exelixis Inc.
$34
Janssen Pharmaceuticals, Inc
$34
Blueprint Medicines Corporation
$26
Seattle Genetics, Inc.
$26
Adaptive Biotechnologies Corporation
$26
Azurity Pharmaceuticals, Inc.
$23
G1 Therapeutics, Inc.
$22
Foundation Medicine, Inc.
$20
Kyowa Kirin, Inc.
$19
Advanced Accelerator Applications
$19
Alnylam Pharmaceuticals Inc.
$18
Shire North American Group Inc
$17
Octapharma USA, Inc.
$17
CSL Behring
$17
Sirtex Medical Inc
$17
Array BioPharma Inc.
$16
Partner Therapeutics, Inc.
$16
Sun Pharmaceutical Industries Inc.
$15
SUN PHARMACEUTICAL INDUSTRIES INC.
$14
Deciphera Pharmaceuticals Inc.
$14
Jazz Pharmaceuticals Inc.
$14
Sobi, Inc
$13
Sysmex Inostics Inc
$12
Secura Bio, Inc.
$12
Veracyte, Inc.
$2
Top 3 companies account for 21.5% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · AMS · AYVAKIT · Abraxane · Afstyla · Alecensa · Aliqopa · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CYRAMZA · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · EXKIVITY · Enhertu · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Fulphila · GAMMAGARD · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INTRAROSA · Imbruvica · JAKAFI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LEUKINE · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONPATTRO · OPDIVO · OPDUALAG · ORGOVYX · Ogivri · Onivyde · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POLIVY · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pedmark · Phesgo · Pomalyst · Prolia · QINLOCK · QUZYTTIR · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Trodelvy · VARUBI · VENCLEXTA · VERZENIO · VIVIMUSTA · VOTRIENT · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xofigo · YONSA · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $8 per 100 Medicare services performed
Geographic Context
Hematologists within 10 mi
4
Per 100K population
2.4
County median income
$71,049
Nearest hospital
CLEVELAND CLINIC INDIAN RIVER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Byer is a mixed practice specialist, with above-average Medicare volume (top 13% in FL), with low-engagement industry engagement, with 15 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Byer experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Byer performed 75,480 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Byer receive payments from pharmaceutical companies?
Yes. Dr. Byer received a total of $20,223 from 84 companies across 1,146 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Byer's costs compare to other hematologists in Vero Beach?
Dr. Byer's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Byer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Vero Beach
Browse hematologists in Vero Beach ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology